scholarly article | Q13442814 |
P356 | DOI | 10.1017/S147895151900066X |
P698 | PubMed publication ID | 31535613 |
P50 | author | Hanneke Poort | Q89932429 |
P2093 | author name string | Jennifer S Temel | |
Joseph A Greer | |||
William F Pirl | |||
Jamie M Jacobs | |||
P2860 | cites work | Predictors of fatigue in cancer patients: a longitudinal study | Q91214970 |
The hospital anxiety and depression scale | Q27860968 | ||
Clinically Relevant Four-Level Cancer-Related Fatigue Among Patients With Various Types of Cancer | Q28074651 | ||
Normative data for functional assessment of cancer therapy--general scale and its use for the interpretation of quality of life scores in cancer survivors | Q30934359 | ||
The validity of the Hospital Anxiety and Depression Scale. An updated literature review | Q34113060 | ||
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure | Q34361336 | ||
Cancer-related fatigue: the scale of the problem | Q34580391 | ||
Quality of life: a new perspective for cancer patients | Q34988275 | ||
Oral cancer treatment: developments in chemotherapy and beyond | Q34998692 | ||
Patient education: the cornerstone of successful oral chemotherapy treatment | Q35620471 | ||
Overview of the changing paradigm in cancer treatment: oral chemotherapy | Q36806145 | ||
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial | Q36914459 | ||
2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy | Q37063671 | ||
Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer. | Q37192605 | ||
Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy | Q37385178 | ||
The challenges of oral agents as antineoplastic treatments | Q37868224 | ||
Psychotropic medications in patients with cancer | Q39679139 | ||
The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. | Q41016479 | ||
Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study. | Q41118725 | ||
Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM). | Q42927824 | ||
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib | Q43675594 | ||
Fatigue in advanced cancer: a prospective study | Q46045358 | ||
Prevalence, Impact, and Correlates of Severe Fatigue in Patients With Gastrointestinal Stromal Tumors. | Q47738372 | ||
Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults | Q47978515 | ||
Severe fatigue during the palliative treatment phase of cancer: an exploratory study | Q48253827 | ||
Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study | Q48659321 | ||
Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer | Q48662294 | ||
Psychopharmacologic applications to cancer. An overview | Q49131666 | ||
Predictors of fatigue and work ability in cancer survivors | Q50204669 | ||
An Automated Intervention Did Not Improve Adherence to Oral Oncolytic Agents While Managing Symptoms: Results From a Two-Arm Randomized Controlled Trial | Q57170285 | ||
Changes in the prescription patterns of psychotropic drugs for cancer patients during a 10-year period | Q57348553 | ||
Innovations and Dilemmas in Psychosocial Oncology: Contributions from the 10th Conference of the European Society for Psychosocial Oncology | Q57423084 | ||
The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory | Q74635584 | ||
General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G) | Q81685445 | ||
P433 | issue | 2 | |
P304 | page(s) | 141-147 | |
P577 | publication date | 2020-04-01 | |
P1433 | published in | Palliative and Supportive Care | Q15758536 |
P1476 | title | Fatigue in patients on oral targeted or chemotherapy for cancer and associations with anxiety, depression, and quality of life | |
P478 | volume | 18 |